Sign inJoin waitlistJoin the waitlist

JM

Jasnoor Malhotra

Credentials: ·

History

Residency
2026–2029
Saint Louis University School of Medicine
2022–2026

Research

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Nature Medicine · 2022 · 433 citations
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Nature Medicine · 2024 · Co-first of 29 authors · 91 citations
Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma
JCO Precision Oncology · 2023 · 21 citations

Sumanta Pal
11 papers
Alexander Chehrazi-Raffle
10 papers · 8 as a fellow
Luis Meza
10 papers · 10 as a resident
ZZ
Zeynep Zengin
10 papers
Nazli Dizman
8 papers · 8 as a resident
Neal Chawla
8 papers · 8 as a fellow
TD
Tanya Dorff
8 papers
Amiesh Govindarajan
7 papers · 7 as a resident
Errol Philip
6 papers
Ramya Muddasani
6 papers · 6 as a fellow
Abhishek Tripathi
5 papers
SL
Sandy Liu
3 papers